Subhani M. Okarvi
- Radiology, Nuclear Medicine and Imaging top 2%
- Oncology top 5%
- Molecular Biology
- Epidemiology
- Pulmonary and Respiratory Medicine
- Co-authors
- Melpomeni FaniHelmut R. MaëckeIbrahim Al‐JammazSuad Bin AmerP. AdriaensAlfons VerbruggenNorah AlhokbanyDavid S. Wishart
- Topics
- Radiopharmaceutical Chemistry and Applications (42 papers)Peptidase Inhibition and Analysis (19 papers)Medical Imaging Techniques and Applications (13 papers)
- Partner nations
- Saudi ArabiaCanadaBelgium
In The Last Decade
Subhani M. Okarvi
45 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 79
- Radiology, Nuclear Medicine and Imaging 851
- Oncology 521
- Molecular Biology 415
- Epidemiology 189
- Pulmonary and Respiratory Medicine 163
Countries citing papers authored by Subhani M. Okarvi
This map shows the geographic impact of Subhani M. Okarvi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Subhani M. Okarvi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Subhani M. Okarvi more than expected).
Fields of papers citing papers by Subhani M. Okarvi
This network shows the impact of papers produced by Subhani M. Okarvi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Subhani M. Okarvi. The network helps show where Subhani M. Okarvi may publish in the future.
Co-authorship network of co-authors of Subhani M. Okarvi
This figure shows the co-authorship network connecting the top 25 collaborators of Subhani M. Okarvi. A scholar is included among the top collaborators of Subhani M. Okarvi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Subhani M. Okarvi. Subhani M. Okarvi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 3 | |
| 3 | 17 | |
| 4 | 25 | |
| 5 | 3 | |
| 6 | 2 | |
| 7 | 1 | |
| 8 | 10 | |
| 9 | 10 | |
| 10 | 5 | |
| 11 | 264 | |
| 12 | 23 | |
| 13 | Design, synthesis, radiolabeling and in vitro and in vivo characterization of tumor-antigen- and antibody-derived peptides for the detection of breast cancer. | 13 |
| 14 | 117 | |
| 15 | 44 | |
| 16 | 17 | |
| 17 | 189 | |
| 18 | 168 | |
| 19 | 3 | |
| 20 | Labeling and biodistribution in mice of terminal oxamide derivatives of tc-99m-mag3 | 1 |
About Subhani M. Okarvi
Subhani M. Okarvi is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 1.2k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (42 papers), Peptidase Inhibition and Analysis (19 papers) and Medical Imaging Techniques and Applications (13 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (851 citations), Oncology (521 citations) and Pharmaceutical Science (77 citations). Subhani M. Okarvi has collaborated with scholars based in Saudi Arabia, Canada and Belgium. Frequent co-authors include Melpomeni Fani, Helmut R. Maëcke, Ibrahim Al‐Jammaz, Suad Bin Amer, P. Adriaens, Alfons Verbruggen, Norah Alhokbany, David S. Wishart, Kristin Verbeke and Amir Reza Jalilian. Their work appears in journals such as Molecules, Theranostics and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.